Introduction
On International Neonatal Screening Day, the ImmunoIVD team joined the global community in recognizing the life-saving importance of newborn screening — one of public health’s most impactful tools.
This day also honors Dr. Robert Guthrie, whose groundbreaking work in developing the bloodspot test for newborn screening has saved countless lives and transformed newborn screening.
To mark the occasion, the ImmunoIVD team came together to celebrate and reflect on our shared mission: providing reliable and accessible assays for early detection of conditions such as Severe Combined Immunodeficiency (SCID), Spinal Muscular Atrophy (SMA), and X-linked Agammaglobulinemia (XLA). These are conditions where early diagnosis enables timely treatment and better outcomes.
Significant progress has been made in screening for SCID and SMA, but access still varies widely between countries.
International Neonatal Screening Day shines a light on these challenges and celebrates collaboration, innovation, and best practices that help ensure every newborn has the chance for a healthy start in life. At ImmunoIVD, we’re proud to be part of that effort.
